Novel therapies targeting vascular endothelium

Endothelium : Journal of Endothelial Cell Research
Dimitris TousoulisChristodoulos Stefanadis

Abstract

Endothelial dysfunction has been identified as a major mechanism involved in all the stages of atherogenesis. Evaluation of endothelial function seems to have a predictive role in humans, and therapeutic interventions improving nitric oxide bioavailability in the vasculature may improve the long-term outcome in healthy individuals, high-risk subjects, or patients with advanced atherosclerosis. Several therapeutic strategies are now available, targeting both the synthesis and oxidative inactivation of nitric oxide (NO) in human vasculature. Statins seem to be currently the most powerful category of these agents, improving endothelial function and decreasing cardiovascular risk after long-term administration. Other cardiovascular agents improving endothelial function in humans are angiotensin-converting enzyme inhibitors/angiotensin receptors blockers, which increase NO bioavailability by modifying the rennin-angiotensin-aldosterone system. Newer therapeutic approaches targeting endothelial dysfunction in specific disease states include insulin sensitizers, L-arginine (the substrate for endothelial NO synthase [eNOS]) as well as substances that target eNOS "coupling," such as folates or tetrahydrobiopterin. Although there are a v...Continue Reading

References

Feb 23, 1995·The New England Journal of Medicine·T J AndersonP Ganz
Jun 1, 1993·The Journal of Clinical Investigation·Y OharaD G Harrison
May 15, 1998·Journal of the American College of Cardiology·M J MullenJ E Deanfield
Sep 3, 1998·The Journal of Biological Chemistry·U Laufs, J K Liao
Nov 20, 1998·European Heart Journal·P C ToutouzasG J Davies
Apr 24, 1999·The American Journal of Cardiology·U IkedaK Shimada
May 6, 1999·Diabetic Medicine : a Journal of the British Diabetic Association·R McFarlaneD K Yue
Oct 8, 1999·Biochemical and Biophysical Research Communications·S Milstien, Z Katusic
Jun 13, 2000·Circulation Research·E S StroesT J Rabelink
Jul 25, 2000·Biochemical and Biophysical Research Communications·N Grosser, H Schröder
Nov 15, 2000·International Journal of Cardiology·C TentolourisP Toutouzas
Jul 14, 2001·Arteriosclerosis, Thrombosis, and Vascular Biology·S N DoshiJ Goodfellow
Aug 2, 2001·Journal of Atherosclerosis and Thrombosis·Y WatanabeH Yamaguchi
Aug 11, 2001·British Journal of Pharmacology·M N MuscaráJ L Wallace
Jan 5, 2002·The New England Journal of Medicine·G SchnyderO M Hess
Jan 31, 2002·Proceedings of the National Academy of Sciences of the United States of America·Claudio NapoliLouis J Ignarro
Apr 23, 2002·Journal of the Renin-angiotensin-aldosterone System : JRAAS·P Sleight
May 11, 2002·American Journal of Physiology. Heart and Circulatory Physiology·Mathew Eric HyndmanHoward G Parsons
Jul 18, 2002·Nature Reviews. Drug Discovery·John L WallaceStefano Fiorucci
Sep 19, 2002·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Stefano FiorucciSalvador Moncada
Jan 30, 2003·Vascular Medicine·Dimitris TousoulisPavios Toutouzas

❮ Previous
Next ❯

Citations

Jan 29, 2011·The British Journal of Nutrition·Kevin D Ballard
Nov 4, 2010·Nature Reviews. Nephrology·Takahiko NakagawaQiuhong Li
Jun 12, 2013·Proceedings of the National Academy of Sciences of the United States of America·Poornima KolharSamir Mitragotri
Jul 17, 2008·Vascular Health and Risk Management·Y C ChanM G Irwin
Mar 7, 2012·Expert Review of Cardiovascular Therapy·Christine KoulisTerri J Allen
Oct 7, 2010·Expert Opinion on Investigational Drugs·Dimitris TousoulisChristodoulos Stefanadis
Dec 18, 2013·Metabolism: Clinical and Experimental·Andreas OberbachHolger Till
May 23, 2012·Pharmacology & Therapeutics·Dimitris TousoulisChristodoulos Stefanadis
Jun 12, 2010·International Journal of Cardiology·Dimitris TousoulisChristodoulos Stefanadis
May 16, 2008·Advanced Drug Delivery Reviews·Katherine W Ferrara
Jun 16, 2007·International Journal of Cardiology·Dimitris TousoulisChristodoulos Stefanadis
Oct 5, 2011·Cardiovascular Therapeutics·Kailash Prasad
Feb 14, 2012·Current Opinion in Pharmacology·Marios MargaritisCharalambos Antoniades
Mar 21, 2009·American Journal of Hypertension·Gerasimos SiasosChristodoulos Stefanadis
Nov 26, 2008·European Heart Journal·Charalambos AntoniadesChristodoulos Stefanadis
May 1, 2007·Cardiovascular Drugs and Therapy·Vineet ChopraErdal Cavusoglu
Sep 11, 2013·Annals of Biomedical Engineering·Shengping QinKatherine W Ferrara
Sep 14, 2011·Current Opinion in Clinical Nutrition and Metabolic Care·Sonja GrafMartina Heer

❮ Previous
Next ❯

Related Concepts

Related Feeds

Atherosclerosis Disease Progression

Atherosclerosis is the buildup of plaque on artery walls, causing stenosis which can eventually lead to clinically apparent cardiovascular disease. Find the latest research on atherosclerosis disease progression here.

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.